Brief: Irhythm Technologies Enters License Agreement With Biointellisense For Multiparameter Sensor Technology To Be Used In Ambulatory Cardiac Monitoring
04/09/2024 12:41
iRhythm Technologies Inc IRTC.O :
* IRHYTHM TECHNOLOGIES ENTERS LICENSE AGREEMENT WITH
BIOINTELLISENSE FOR MULTIPARAMETER SENSOR TECHNOLOGY TO BE USED
IN AMBULATORY CARDIAC MONITORING
* IRHYTHM TECHNOLOGIES INC: BIOINTELLISENSE WILL ALSO BE
ELIGIBLE
TO RECEIVE ROYALTIES ON ANNUAL NET SALES OF PRODUCTS AND
SERVICES
Source text for Eikon: ID:nGNXFK6Lm
Further company coverage: IRTC.O
Recent news on iRhythm Holdings
See all newsiRhythm Holdings, Inc reports results for the quarter ended September 30 - Earnings Summary
iRhythm Q3 revenue slightly misses estimates; net loss widens YoY
Brief: iRhythm Holdings Q3 Revenue USD 221.6 Million Vs. IBES Estimate USD 222.5 Million
Brief: Irhythm Provides Update On Cybersecurity Incident Previously Disclosed In June 2026
Factbox: US companies face rise in cyber attacks